Evidence map›Paper›PMID 9401815›Full record

ArticleGrowth factors (Chur, Switzerland)1997

Influence of PDGF-BB on proliferation and transition through the MyoD-myogenin-MEF2A expression program during myogenesis in mouse C2 myoblasts.

Z Yablonka-Reuveni, A J Rivera

Open access · greenAbstract read
In one paragraph

Article in Growth factors (Chur, Switzerland), 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Z Yablonka-ReuveniDepartment of Biological Structure, School of Medicine, University of Washington, Seattle 98195, USA. reuveni@u.washington.edu
A J Rivera
University of Washington · US

Funding

Satellite Cells and Skeletal Muscle Growth DynamicsR01AG013798 · NIA · UNIVERSITY OF WASHINGTON · PI YABLONKA-REUVENI, ZIPORA · 1995 to 2008
$1.8M
SKELETAL MUSCLE SATELLITE CELLR29AR039677 · NIAMS · UNIVERSITY OF WASHINGTON · PI YABLONKA-REUVENI, ZIPORA · 1989 to 1993
–
NIAMS NIH HHS R29 AR039677NIA NIH HHS AG13798NIA NIH HHS R01 AG013798
6 · The paper itself

Abstract

We have previously demonstrated that PDGF-BB enhances proliferation of C2 myoblasts. This has led us to examine whether the mitogenic influence of PDGF-BB in the C2 model correlates with modulation of specific steps associated with myogenic differentiation. C2 myoblasts transiting through these differentiation specific steps were monitored via immunocytochemistry. We show that the influence of PDGF on enhancing cell proliferation correlates with a delay in the emergence of cells positive for sarcomeric myosin. We further monitored the influence of PDGF-BB on differentiation steps preceding the emergence of myosin+ cells. We demonstrate that mononucleated C2 cells first express MyoD (MyoD+/myogenin- cells) and subsequently, myogenin. Cells negative for both MyoD and myogenin (the phenotype preceding the MyoD+ state) were present at all times in culture and comprised the majority, if not all, of the cells which responded mitogenically to PDGF. Additionally, the frequency of the MyoD+/myogenin+ cell phenotype was reduced in cultures receiving PDGF, suggesting that PDGF can modulate the transition of the cells into the myogenin+ state. We determined that many of the myogenin+ cells subsequently become MEF2A+ and this phenomenon is not influenced by PDGF-BB. FGF-2 also enhanced the proliferation of C2 myoblasts and suppressed the appearance of the myogenin+ cells, but did not influence the subsequent transition into the MEF2A+ state. The study raises the possibility that PDGF-BB and FGF-2 might delay the transition of the C2 cells into the MyoD+/myogenin+ state by depressing a paracrine signal that enhances differentiation.

Indexed as

AnimalsBecaplerminBromodeoxyuridineCell CountCell DifferentiationCell DivisionCell LineClone CellsCyclin ADesminDNA-Binding ProteinsFibroblast Growth Factor 2Fluorescent Antibody TechniqueImmunohistochemistryMEF2 Transcription FactorsMiceBecaplerminBromodeoxyuridineCyclin ADesminDNA-Binding ProteinsFibroblast Growth Factor 2Mef2a protein, mouseMEF2 Transcription FactorsMyoD ProteinMyogenic Regulatory FactorsMyogeninMyog protein, mouseMyosinsPlatelet-Derived Growth FactorProto-Oncogene Proteins c-sisTranscription Factors

Identifiers

PMID9401815
PMCPMC4096310
OpenAlexW2096226963

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.